These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24478269)

  • 1. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
    Theunissen EA; Bosma SC; Zuur CL; Spijker R; van der Baan S; Dreschler WA; de Boer JP; Balm AJ; Rasch CR
    Head Neck; 2015 Feb; 37(2):281-92. PubMed ID: 24478269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N; Kaushal D; Patro SK; Pareek P; Dixit A; Soni K; Prakasan Nair N; Choudhury B; Goyal A
    Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
    Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S
    J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: A machine learning and multi-variable modelling study.
    Abdollahi H; Mostafaei S; Cheraghi S; Shiri I; Rabi Mahdavi S; Kazemnejad A
    Phys Med; 2018 Jan; 45():192-197. PubMed ID: 29329660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
    Espenel S; Garcia MA; Guy JB; Vallard A; Ben Mrad M; Langrand-Escure J; El Meddeb Hamrouni A; Trone JC; Xia Y; Rancoule C; Magné N
    Cancer Radiother; 2017 Feb; 21(1):77-83. PubMed ID: 28189351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.
    Cheraghi S; Nikoofar P; Fadavi P; Bakhshandeh M; Khoie S; Gharehbagh EJ; Farahani S; Mohebbi A; Vasheghani M; Zare M; Nikoofar A; Mahdavi SR
    Med Oncol; 2015 Jul; 32(7):200. PubMed ID: 26071124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
    Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
    Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
    Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review.
    Mujica-Mota M; Waissbluth S; Daniel SJ
    Head Neck; 2013 Nov; 35(11):1662-8. PubMed ID: 23280686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
    Theunissen EA; Zuur CL; Józwiak K; Lopez-Yurda M; Hauptmann M; Rasch CR; van der Baan S; de Boer JP; Dreschler WA; Balm AJ
    JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):810-5. PubMed ID: 26291150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.
    Schmitt NC; Page BR
    Int J Audiol; 2018 Sep; 57(sup4):S49-S54. PubMed ID: 28728452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer.
    Schuette A; Lander DP; Kallogjeri D; Collopy C; Goddu S; Wildes TM; Daly M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):106-112. PubMed ID: 31750863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
    Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
    Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
    Madasu R; Ruckenstein MJ; Leake F; Steere E; Robbins KT
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):978-81. PubMed ID: 9305250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy.
    Niemensivu R; Saarilahti K; Ylikoski J; Aarnisalo A; Mäkitie AA
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2509-14. PubMed ID: 26685859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
    Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.